[1] LI Y, WU Y, WU L L, et al.The effects of probiotic administration on patients with prediabetes:A meta-analysis and systematic review[J].Journal of Translational Medicine, 2022, 20(1):498.
[2] GALICIA-GARCIA U, BENITO-VICENTE A, JEBARI S, et al.Pathophysiology of type 2 diabetes mellitus[J].International Journal of Molecular Sciences, 2020, 21(17):6275.
[3] LIU H D, XING Y, WANG Y B, et al.Dendrobium officinale polysaccharide prevents diabetes via the regulation of gut microbiota in prediabetic mice[J].Foods, 2023, 12(12):2310.
[4] KHETAN A K, RAJAGOPALAN S.Prediabetes[J].Canadian Journal of Cardiology, 2018, 34(5):615-623.
[5] SÁNCHEZ B, DELGADO S, BLANCO-MÍGUEZ A, et al.Probiotics, gut microbiota, and their influence on host health and disease[J].Molecular Nutrition & Food Research, 2017, 61(1).DOI:10.1002/mnfr.201600240.
[6] LUC K, SCHRAMM-LUC A, GUZIK T J, et al.Oxidative stress and inflammatory markers in prediabetes and diabetes[J].Journal of Physiology and Pharmacology, 2019, 70(6).DOI:10.26402/jpp.2019.6.01.
[7] MOHAMADSHAHI M, VEISSI M, HAIDARI F, et al.Effects of probiotic yogurt consumption on inflammatory biomarkers in patients with type 2 diabetes[J].BioImpacts, 2014, 4(2):83-88.
[8] NAITO E, YOSHIDA Y, KUNIHIRO S, et al.Effect of Lactobacillus casei strain Shirota-fermented milk on metabolic abnormalities in obese prediabetic Japanese men:A randomised, double-blind, placebo-controlled trial[J].Bioscience of Microbiota, Food and Health, 2018, 37(1):9-18.
[9] SCHELLEKENS H, TORRES-FUENTES C, VAN DE WOUW M, et al.Bifidobacterium longum counters the effects of obesity:Partial successful translation from rodent to human[J].EBioMedicine, 2021, 63:103176.
[10] QIAN X, SI Q, LIN G P, et al.Bifidobacterium adolescentis is effective in relieving type 2 diabetes and may be related to its dominant core genome and gut microbiota modulation capacity[J].Nutrients, 2022, 14(12):2479.
[11] CHEN Y, SHEN X, MA T, et al.Adjunctive probio-X treatment enhances the therapeutic effect of a conventional drug in managing type 2 diabetes mellitus by promoting short-chain fatty acid-producing bacteria and bile acid pathways[J].mSystems, 2023, 8(1):e01300-e01322.
[12] WANG H C, SONG W Y, YUAN W W, et al.Modulating the human gut microbiota through hypocaloric balanced diets:An effective approach for managing obesity[J].Nutrients, 2023, 15(14):3101.
[13] 王丽, 周志谟, 卿烈铭, 等.长双歧杆菌婴儿亚种B79介导巨噬细胞对前脂肪细胞成脂分化和脂质代谢的调节作用[J].食品研究与开发, 2025, 46(18):53-61.
WANG L, ZHOU Z M, QING L M, et al.Macrophage-mediated regulatory effects of Bifidobacterium longum subsp.infantis B79 on adipogenesis and lipid metabolism of preadipocytes[J].Food Research and Development, 2025, 46(18):53-61.
[14] 潘子怡, 陈则华, 毛丙永, 等.青春双歧杆菌冻干保护剂筛选及高密度冻干工艺优化[J].食品与生物技术学报, 2024, 43(2):23-29.
PAN Z Y, CHEN Z H, MAO B Y, et al.Screening of lyoprotectants and optimization of high-density freeze-drying process for Bifidobacterium adolescentis[J].Journal of Food Science and Biotechnology, 2024, 43(2):23-29.
[15] WANG K L, KONG L H, WEN X, et al.The positive effect of 6-gingerol on high-fat diet and streptozotocin-induced prediabetic mice:Potential pathways and underlying mechanisms[J].Nutrients, 2023, 15(4):824.
[16] 陈峰, 马微微, 于雷雷, 等.植物乳杆菌CCFM8661增强小鼠免疫力的功能评价[J].食品与生物技术学报, 2024, 43(5):37-43.
CHEN F, MA W W, YU L L, et al.Functional evaluation of lactiplantibacillus plantarum CCFM8661 for enhancing immunity in mice[J].Journal of Food Science and Biotechnology, 2024, 43(5):37-43.
[17] WANG H C, CHEN Y T, FENG L, et al.A gut aging clock using microbiome multi-view profiles is associated with health and frail risk[J].Gut Microbes, 2024, 16(1):2297852.
[18] BI Y R, YANG Y, YUAN X J, et al.Association between liver enzymes and type 2 diabetes:A real-world study[J].Frontiers in Endocrinology, 2024, 15:1340604.
[19] WORETA T A, ALQAHTANI S A.Evaluation of abnormal liver tests[J].The Medical Clinics of North America, 2014, 98(1):1-16.
[20] BLANDINO G, INTURRI R, LAZZARA F, et al.Impact of gut microbiota on diabetes mellitus[J].Diabetes & Metabolism, 2016, 42(5):303-315.
[21] LIU S, QIN P P, WANG J.High-fat diet alters the intestinal microbiota in streptozotocin-induced type 2 diabetic mice[J].Microorganisms, 2019, 7(6):176.
[22] LE GALL M, THENET S, AGUANNO D, et al.Intestinal plasticity in response to nutrition and gastrointestinal surgery[J].Nutrition Reviews, 2019, 77(3):129-143.
[23] YANG M, WANG J H, SHIN J H, et al.Pharmaceutical efficacy of novel human-origin Faecalibacterium prausnitzii strains on high-fat-diet-induced obesity and associated metabolic disorders in mice[J].Frontiers in Endocrinology, 2023, 14:1220044.
[24] PETERSEN M C, SHULMAN G I.Mechanisms of insulin action and insulin resistance[J].Physiological Reviews, 2018, 98(4):2133-2223.
[25] 陈兆斌, 黄丽媛, 王炳元, 等.代谢相关脂肪性肝病与2型糖尿病的关系及共病机制研究进展[J].临床肝胆病杂志, 2023, 39(10):2454-2459.
CHEN Z B, HUANG L Y, WANG B Y, et al.Research advances in the association between metabolic associated fatty liver and type 2 diabetes mellitus and the mechanism of comorbidity[J].Journal of Clinical Hepatology, 2023, 39(10):2454-2459.
[26] MOHAMED J, NAZRATUN NAFIZAH A H, ZARIYANTEY A H, et al.Mechanisms of diabetes-induced liver damage:The role of oxidative stress and inflammation[J].Sultan Qaboos University Medical Journal, 2016, 16(2):e132-e141.
[27] GREEN R M, FLAMM S.AGA technical review on the evaluation of liver chemistry tests[J].Gastroenterology, 2002, 123(4):1367-1384.
[28] ZHU X X, ZHAO C Y, MENG X Y, et al.Bacteroides uniformis ameliorates carbohydrate and lipid metabolism disorders in diabetic mice by regulating bile acid metabolism via the gut-liver axis[J].Pharmaceuticals, 2024, 17(8):1015.
[29] SHE J Q, TUERHONGJIANG G, GUO M Y, et al.Statins aggravate insulin resistance through reduced blood glucagon-like peptide-1 levels in a microbiota-dependent manner[J].Cell Metabolism, 2024, 36(2):408-421.e5.